Q/C Technologies, Inc. Increase (Decrease) in Deferred Revenue
Q/C Technologies, Inc. (QCLS) reported Increase (Decrease) in Deferred Revenue of $12.50 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-14
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was $0.00.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-09-30 was $0.00.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-06-30 was -$222.22K.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-03-31 was -$83.33K.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$305.56K.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$333.33K.
- Q/C Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2013 was -$333.33K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-09-30 | $12.50K 10-Q · filed 2018-11-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-11 | $0.00 derived: sum of 2 quarters · filed 2017-04-11 | -$222.22K derived: sum of 3 quarters · filed 2017-04-11 | -$305.56K 10-K · filed 2017-04-11 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$222.22K derived: sum of 2 quarters · filed 2016-11-14 | -$305.56K 10-Q · filed 2016-11-14 | -$388.89K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$222.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$305.56K 10-Q · filed 2016-08-11 | -$388.89K derived: sum of 3 quarters · filed 2016-08-11 | -$472.22K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$83.33K 10-Q · filed 2016-05-12 | -$166.67K derived: sum of 2 quarters · filed 2016-05-12 | -$250.00K derived: sum of 3 quarters · filed 2016-05-12 | -$333.33K derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$83.33K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$166.67K derived: sum of 2 quarters · filed 2016-03-30 | -$250.00K derived: sum of 3 quarters · filed 2016-03-30 | -$333.33K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$83.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$166.67K derived: sum of 2 quarters · filed 2015-11-13 | -$250.00K 10-Q · filed 2015-11-13 | -$333.33K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$83.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-18 | -$166.67K 10-Q · filed 2015-08-18 | -$250.00K derived: sum of 3 quarters · filed 2015-08-18 | -$333.33K derived: sum of 4 quarters · filed 2015-08-18 |
| 2014-03-31 | -$83.33K 10-Q · filed 2015-05-14 | -$166.67K derived: sum of 2 quarters · filed 2015-05-14 | -$250.00K derived: sum of 3 quarters · filed 2015-05-14 | -$333.33K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | -$83.33K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | -$166.67K derived: sum of 2 quarters · filed 2015-03-23 | -$250.00K derived: sum of 3 quarters · filed 2015-03-23 | -$333.33K 10-K · filed 2015-03-23 |
| 2013-09-30 | -$83.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$166.67K derived: sum of 2 quarters · filed 2014-11-13 | -$250.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$83.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$166.67K 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | -$83.33K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |